Modica, Roberta
 Distribuzione geografica
Continente #
NA - Nord America 413
EU - Europa 172
AS - Asia 71
Continente sconosciuto - Info sul continente non disponibili 1
Totale 657
Nazione #
US - Stati Uniti d'America 407
IT - Italia 99
CN - Cina 56
UA - Ucraina 17
SE - Svezia 16
VN - Vietnam 12
IE - Irlanda 10
FI - Finlandia 9
DE - Germania 7
CA - Canada 6
GB - Regno Unito 6
FR - Francia 3
NL - Olanda 3
IN - India 2
EU - Europa 1
JP - Giappone 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 657
Città #
Chandler 185
Millbury 23
Beijing 21
Des Moines 20
Napoli 19
Naples 18
Boston 15
Jacksonville 15
Lawrence 15
Nanjing 14
Princeton 13
Dong Ket 12
Wilmington 11
Ashburn 8
Nanchang 7
Rome 7
Houston 6
Ottawa 5
Helsinki 4
Boardman 3
Buffalo 3
Hebei 3
Milan 3
Philadelphia 3
Woodbridge 3
Ann Arbor 2
Bari 2
Fairfield 2
London 2
Marcianise 2
Messina 2
Piano Di Sorrento 2
Redwood City 2
Scafati 2
Shenyang 2
Solaro 2
Torre Del Greco 2
Afragola 1
Amsterdam 1
Arienzo 1
Council Bluffs 1
Giugliano In Campania 1
Guangzhou 1
Hangzhou 1
Jiaxing 1
Kagoya 1
Kunming 1
Köln 1
Landshut 1
Lembach 1
Mcallen 1
Mumbai 1
New Delhi 1
Norwich 1
Pozzuoli 1
San Jose 1
Shenzhen 1
Taizhou 1
Tianjin 1
Torino 1
Zhengzhou 1
Totale 484
Nome #
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. 47
Hepatic arterial embolization in patients with neuroendocrine tumors. 41
GLP-1: benefits beyond pancreas. 39
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity and Resilience 36
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 29
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 28
Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature 28
Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature 26
Nutrition and neuroendocrine tumors: An update of the literature. 26
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 25
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors 25
Open issues on G3 neuroendocrine neoplasms: Back to the future 25
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 25
Emerging therapies in pheochromocytoma and paraganglioma: Immune checkpoint inhibitors in the starting blocks 24
Pituitary function and morphology in Fabry disease. 23
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 22
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 22
The safety of available treatments options for neuroendocrine tumors 20
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 20
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 20
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 19
An incidental rectal neuroendocrine microcarcinoma ('micro-NEC') coexistent with a high grade adenoma 17
Erratum to: GLP-1: Benefits beyond pancreas 16
Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions 16
Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors? 16
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery 15
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 12
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study 10
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group 10
Therapeutic strategies for patients with neuroendocrine neoplasms: current perspectives 8
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 7
Risk factors for gastroenteropancreatic neuroendocrine neoplasms ({GEP}-{NENs}): a three-centric case{\textendash}control study 4
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature 3
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 3
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 3
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 3
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 2
No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus 2
PRRT: identikit of the perfect patient 2
Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine‐needle aspiration of neck paraganglioma 2
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 2
Role of Metformin on Recurrence-Free Survival in Neuroendocrine Tumors 2
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 2
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target 2
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study 1
A rare rarity: Neuroendocrine tumor of the esophagus 1
Prognostic significance of laterality in lung neuroendocrine tumors 1
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 1
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms 1
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: Confirmation that R203X is the peculiar AIRE gene mutation 1
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies (Oct, 10.1007/s40618-022-01905-4, 2022) 1
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells? 1
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 1
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 1
Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature 1
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship 1
Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers 1
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 1
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 1
Bone metabolism and vitamin D implication in gastroenteropancreatic neuroendocrine tumors 1
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience (vol 106, pg e316, 2020) 1
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead 1
Carcinoma showing thymus-like differentiation (CASTLE): a case report 1
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 1
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 1
Totale 750
Categoria #
all - tutte 1731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201826 0000 00 08 7056
2018/201923 0030 09 00 2324
2019/202065 20031 63 02 113124
2020/202191 051610 913 91 72613
2021/2022215 20253 514 16 17166462
2022/2023300 31571439 5141 5611 0000
Totale 750